Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome
Abstract Direct-acting antivirals (DAA) have replaced interferon (IFN)-based therapies for hepatitis C virus. In this retrospective clinical study, we examined differences in histopathologic features in paired liver biopsies collected from the same patient before and after DAA and correlated these f...
Saved in:
Main Authors: | Omar A. Saldarriaga, Bradley Dye, Judy Pham, Timothy G. Wanninger, Daniel Millian, Michael Kueht, Benjamin Freiberg, Netanya Utay, Heather L. Stevenson |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/883254453eb34800b1c9c7047f0e7a8d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement
by: Tag-Adeen M, et al.
Published: (2017) -
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
by: Vicente Soriano, et al.
Published: (2022) -
The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
by: Irina RUSU, et al.
Published: (2020) -
Hepatic mitochondrial function analysis using needle liver biopsy samples.
by: Michael J J Chu, et al.
Published: (2013) -
Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.
by: Fei Xiao, et al.
Published: (2014)